KOSDAQ-listed JLK shares were strong early on the 11th. The stock was up for a second straight day on news that JLK's research was published in Stroke, an academic journal issued by the American Heart Association (AHA).
As of 10:03 a.m. that day, JLK was trading at 4,740 won, up 410 won (9.47%) from the previous session.
On the 10th, JLK said that research using artificial intelligence (AI) technology for stroke was published in Stroke, the world's leading stroke journal issued by the American Heart Association (AHA).
The journal said AI technology can analyze CT scans of cerebral infarction patients to calculate "net water uptake (NWU)," allowing physicians to use NWU values to predict the likelihood of severe disability or death three months later. The NWU measurement algorithm is an automated quantification technology based on JLK's AI technology.
This appears to have drawn buying as expectations grew for the use of JLK's AI technology. After the announcement the previous day, JLK shares rose 6.26% to finish the transaction.